OTLK Earnings
Outlook Therapeutics Inc
$
2.130
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Outlook Therapeutics Inc(OTLK) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Outlook Therapeutics Inc earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q3 | 2025-08-13 | After Hours | -0.42 | - | - | 2.55M | - | - | - | - |
| FY2025Q2 | 2025-05-15 | After Hours | -0.55 | -0.40 | +27.27 | 702.60K | 0.00 | -100.00 | +4.48 | -2.69 |
| FY2024Q4 | 2024-12-27 | - | -0.83 | - | - | - | - | - | +18.24 | +31.76 |
| FY2024Q3 | 2024-08-14 | Pre-Market | -1.06 | -0.83 | +21.70 | 1.43M | - | - | -5.29 | -8.39 |
| FY2024Q2 | 2024-05-15 | - | -0.88 | -1.55 | -76.14 | - | - | - | +0.41 | +6.35 |
| FY2024Q1 | 2024-02-14 | - | -0.05 | -0.04 | +20.00 | - | - | - | +5.00 | +4.50 |
| FY2023Q3 | 2023-08-14 | - | -0.04 | -0.08 | -100.00 | 43.75K | - | - | -1.88 | -16.87 |
| - | 2023-05-15 | - | -0.06 | -0.03 | +50.00 | - | - | - | +4.35 | +16.52 |
| - | 2023-02-14 | - | -0.04 | -0.08 | -100.00 | - | - | - | -0.83 | -3.33 |
| - | 2022-12-29 | - | -0.07 | -0.06 | +14.29 | - | - | - | +5.94 | +1.98 |
OTLK Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Outlook Therapeutics Inc reported performance for FY2025Q3, announced on 2025-08-13. The company achieved an EPS of , compared to analyst estimates of -0.42 by % . Revenue for the quarter reached 0.00 compared to expectations of 2.55M by % .
The stock price reacted with a % one-day change and a % five-day change following the earnings release. These movements reflect market reaction in Outlook Therapeutics Inc growth trajectory and strategic initiatives.
OTLK Earnings Forecast
Looking ahead, Outlook Therapeutics Inc(OTLK) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 44.87%, while EPS estimates have been Revise Downward by -34.29%. For the upcoming , revenue estimates have been adjusted Go Up by 4.93% . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Outlook Therapeutics Inc long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between OTLK's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward
+44.87%
In Past 3 Month
Revenue Estimates for Q3 2025
Revise Downward
-34.29%
In Past 3 Month
Stock Price
Go Up
+4.93%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:12.57M
--
EPS Estimate-Annual FY 2025:0
—
Stock Price2.13
OTLK Revenue and EPS Performance: A Historical Perspective
Outlook Therapeutics Inc revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-08-13,After Hours):
EPS: (Actual) vs.-0.42 (Estimate) (%)
Revenue: 0.00 (Actual) vs. 2.55M (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
FY2025Q2 (2025-05-15,After Hours):
EPS: -0.40 (Actual) vs.-0.55 (Estimate) (27.27%)
Revenue: 0.00 (Actual) vs. 702.60K (Estimate) (-100.00%)
Price Reaction: 4.48%(1-Day), -2.69%(5-Day)
FY2024Q4 (2024-12-27,):
EPS: (Actual) vs.-0.83 (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 18.24%(1-Day), 31.76%(5-Day)
Earnings Reaction
The chart below shows how OTLK performed 10 days before and after its earnings report, based on data from the past quarters. Typically, OTLK sees a -3.27% change in stock price 10 days leading up to the earnings, and a +4.45% change 10 days following the report. On the earnings day itself, the stock moves by +2.39%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed % on the day following the earnings release and then changed by 0% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
People Also Watch
XLO
Xilio Therapeutics Inc
0.715
USD
+2.14%
CGBS
Crown LNG Holdings Ltd
0.017
USD
-64.69%
SPRU
Spruce Power Holding Corp
1.420
USD
+2.90%
GROV
Grove Collaborative Holdings Inc
1.470
USD
-0.68%
PVL
Permianville Royalty Trust
1.860
USD
+0.54%
FTCI
FTC Solar Inc
4.810
USD
0.00%
ICAD
ICAD Inc
3.870
USD
+3.62%
OVID
Ovid Therapeutics Inc
0.858
USD
+56.86%
AP
Ampco-Pittsburgh Corp
3.210
USD
-5.59%
MAIA
Maia Biotechnology Inc
1.600
USD
+1.91%
FAQ
What were the key highlights of OTLK’s latest earnings report for FY2025Q3?
OTLK reported its FY2025Q3 earnings on 2025-08-13, showcasing a revenue of 0.00 against an estimate of 2.55M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.42 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.
How did OTLK’s stock price react after the FY2025Q3 earnings release?
What are the revenue and EPS estimates for OTLK for undefined?
How does OTLK’s stock price correlate with earnings forecast revisions?
What should investors expect from OTLK’s next earnings report?